Neurocrine Biosciences, Inc.
USD170.00
+1.48 (+0.88%)
CEO
Kyle W. Gano
IPO Date
1996-05-23
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$168.83
Prev. Close
$168.52
Day Low
$168.83
Day High
$171.43
52W Low
$122.14
52W High
$171.43
Market Cap
$17.09B
Volume
1.35M
| 10,000 |
| $79.79 |
| 9 Jun 2026 | SHERWIN STEPHEN A | director | S-Sale | Disposed | 7,883 | $163.81 |
| 9 Jun 2026 | SHERWIN STEPHEN A | director | S-Sale | Disposed | 2,549 | $164.44 |
| 9 Jun 2026 | SHERWIN STEPHEN A | director | S-Sale | Disposed | 6,896 | $165.79 |
| 9 Jun 2026 | SHERWIN STEPHEN A | director | S-Sale | Disposed | 5,829 | $166.56 |
| 9 Jun 2026 | SHERWIN STEPHEN A | director | S-Sale | Disposed | 1,843 | $167.31 |
| 9 Jun 2026 | SHERWIN STEPHEN A | director | M-Exempt | Disposed | 15,000 | $53.64 |
| 9 Jun 2026 | SHERWIN STEPHEN A | director | M-Exempt | Disposed | 10,000 | $79.79 |
| 9 Jun 2026 | Onyia Jude | Chief Scientific Officer | G-Gift | Disposed | 2,441 | $0.00 |
| 18 Sept 2024 | Michael McCaul | Michael McCaul | Sale | $1,001 - $15,000 |
| 17 Nov 2023 | Michael McCaul | Michael McCaul | Sale | $15,001 - $50,000 |
| 17 Nov 2023 | Michael McCaul | Michael McCaul | Sale | $50,001 - $100,000 |
| 20 Sept 2023 | Michael McCaul | Michael McCaul | Purchase | $50,001 - $100,000 |
| 20 Sept 2023 | Michael McCaul | Michael McCaul | Purchase | $15,001 - $50,000 |
| 22 Jun 2023 | Michael McCaul | Michael McCaul | Sale | $15,001 - $50,000 |
| 8 Mar 2023 | Ro Khanna | Ro Khanna | Sale | $1,001 - $15,000 |